Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

Cited by (894)

Items 101–200 of 894

1. Can volatile compounds in exhaled breath be used to monitor control in diabetes mellitus?
   David Cecil Smith, Patrik Španěl, Anthony A. Fryer, Fahmy Hanna, Gordon A. Ferns · 2011 · Journal of Breath Research
2. Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence
   Sun Joon Moon, Inha Jung, Cheol‐Young Park · 2021 · Diabetes & Metabolism Journal
3. Care of diabetes in children and adolescents: controversies, changes, and consensus
   Cameron, Fergus J, Wherrett, Diane K · 2015 · The Lancet
4. Accuracy of the Enlite 6-Day Glucose Sensor with Guardian and Veo Calibration Algorithms
   Desmond Barry Keenan, John J. Mastrototaro, Howard Zisser, Kenneth A. Cooper, Raghavendhar Gautham, Scott W. Lee, Jonathan Yusi, Timothy Silleck Bailey, Ronald Brazg, Rajiv V. Shah · 2011 · Diabetes Technology & Therapeutics
5. Monitoring Glycemic Control
   Lori Berard, Ian R. Blumer, Robyn L. Houlden, David B. Miller, Vincent C. Woo · 2013 · Canadian Journal of Diabetes
6. Closed-loop insulin delivery for treatment of type 1 diabetes
   Daniela Elleri, David B. Dunger, Roman Hovorka · 2011 · BMC Medicine
7. Racial disparities in treatment and outcomes of children with type 1 diabetes
   Terri Hendler Lipman, Jennifer A. Smith, Oona Patil, Steven Matthew Willi, Colin P. Hawkes · 2020 · Pediatric Diabetes
8. Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial
   Tumminia, Andrea, Crimi, Salvatore, Sciacca, Laura, Buscema, Massimo, Frittitta, Lucia, Squatrito, Sebastiano, Vigneri, Riccardo, Tomaselli, Letizia · 2015 · Diabetes/Metabolism Research and Reviews
9. Adherence to Glycemic Monitoring in Diabetes
   Susana R. Patton · 2015 · Journal of Diabetes Science and Technology
10. Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens
    Jean‐Pierre Riveline, Pauline Schaepelynck, Lucy Chaillous, Éric Renard, Agnes Sola‐Gazagnes, Alfred Penfornis, Nadia Tubiana‐Rufi, V. Sulmont, Bogdan Catargi, Céline Lukas et al. · 2012 · Diabetes Care
11. Diabetic gastroparesis
    Koch, Kenneth L., Calles-Escandón, Jorge · 2015 · Gastroenterology Clinics of North America
12. Continuous glucose monitoring in type 1 diabetes
    Nelly Mauras, Larry A. Fox, KIMBERLY A. ENGLERT, Roy W. Beck · 2012 · Endocrine
13. Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
    Andreas Neu, Jutta Bürger-Büsing, Thomas Danne, Axel Dost, Martin Holder, Reinhard Walter Holl, PM Holterhus, T Kapellen, Beate Karges, Olga Kordonouri et al. · 2016 · Diabetologie und Stoffwechsel
14. Design and Evaluation of a Robust PID Controller for a Fully Implantable Artificial Pancreas
    Lauren M. Huyett, Eyal Dassau, Howard Zisser, Francis J. Doyle · 2015 · Industrial & Engineering Chemistry Research
15. The Effect of Walking on Postprandial Glycemic Excursion in Patients With Type 1 Diabetes and Healthy People
    Manohar, Chinmay, Levine, James A., Nandy, Debashis K., Saad, Ahmed, Dalla Man, Chiara, McCrady-Spitzer, Shelly K., Basu, Rita, Cobelli, Claudio, Carter, Rickey E., Basu, Ananda et al. · 2012 · Diabetes Care
16. Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes
    Ahmad Haidar, RÉMI P.R. RABASA-LHORET, Laurent Legault, Leif Erik Lovblom, Rohan Rakheja, Virginie Messier, Émilie D'Aoust, C. Marcelo Falappa, Tara D. Justice, Andrej Orszag et al. · 2015 · The Journal of Clinical Endocrinology & Metabolism
17. Implantable drug delivery systems
    Anoop Kumar, Jonathan D. Pillai · 2018 · Elsevier eBooks
18. The Use of an Automated, Portable Glucose Control System for Overnight Glucose Control in Adolescents and Young Adults With Type 1 Diabetes
    Michael Joseph O'Grady, Adam J. Retterath, Desmond Barry Keenan, Natalie Kurtz, Martin Cantwell, Glenn Spital, Michael N. Kremliovsky, Anirban Roy, Elizabeth Ann Davis, Timothy William Jones et al. · 2012 · Diabetes Care
19. Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes
    Slattery, David, Choudhary, Pratik · 2017 · Diabetes Technology & Therapeutics
20. Type 1 Diabetes in Children and Adolescents
    Diane K. Wherrett, Josephine Ho, Céline Huot, Laurent Legault, Meranda Michel Nakhla, Elizabeth T. Rosolowsky · 2018 · Canadian Journal of Diabetes
21. Usage and Effectiveness of the Low Glucose Suspend Feature of the Medtronic Paradigm Veo Insulin Pump
    Pratik K. Agrawal, John B. Welsh, Brian Kannard, Sina Askari, Qingqing Yang, FRANCINE RATNER KAUFMAN · 2011 · Journal of Diabetes Science and Technology
22. Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies
    Lori M. Laffel · 2016 · Diabetes Technology & Therapeutics
23. Patient experience of hypoglycaemia unawareness in Type 1 diabetes: are patients appropriately concerned?
    Helen Rogers, Nicole de Zoysa, Stephanie A. Amiel · 2011 · Diabetic Medicine
24. Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy
    Garg, Satish K., Voelmle, Mary K., Beatson, Christie R., Miller, Hayley A., Crew, Lauren B., Freson, Brandon J., Hazenfield, Rachel M. · 2011 · Diabetes Care
25. A Clinical Trial of the Accuracy and Treatment Experience of the Dexcom G4 Sensor (Dexcom G4 System) and Enlite Sensor (Guardian REAL-Time System) Tested Simultaneously in Ambulatory Patients with Type 1 Diabetes
    Viktorija Matuleviciene, Jeffrey I. Joseph, Mervi Andelin, Irl B. Hirsch, Stig Attvall, Aldina Pivodic, Sofia Dahlqvist, David Charles Klonoff, Börje S. Haraldsson, Marcus Lind · 2014 · Diabetes Technology & Therapeutics
26. The Artificial Pancreas and Meal Control: An Overview of Postprandial Glucose Regulation in Type 1 Diabetes
    Anas El Fathi, Mohamed Raef Smaoui, V. Gingras, Benoit Boulet, A. Haidar · 2018 · IEEE Control Systems
27. Evolution of Diabetes Technology
    Klemen Dovč, Tadej Battelino · 2019 · Endocrinology and Metabolism Clinics of North America
28. Health-Related Quality of Life and Treatment Satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) Trial
    Richard R. Rubin, Mark F. Peyrot, for the STAR 3 Study Group · 2011 · Diabetes Technology & Therapeutics
29. Real-Life Utilization of Real-Time Continuous Glucose Monitoring: The Complete Picture
    Neesha Ramchandani, Sandeep Arya, Svetlana Ten, Sonal Bhandari · 2011 · Journal of Diabetes Science and Technology
30. Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial
    Martin Tauschmann, Janet M. Allen, Malgorzata E. Wilinska, Hood Thabit, Carlo L. Acerini, David B. Dunger, Roman Hovorka · 2016 · Diabetes Care
31. DNA Aptamer Raised Against AGEs Blocks the Progression of Experimental Diabetic Nephropathy
    Yusuke Kaida, Kei Fukami, Takanori Matsui, Yuichiro Higashimoto, Yuri Nishino, Nana Obara, Yosuke Nakayama, Ryotaro Ando, Maki Toyonaga, Seiji Ueda et al. · 2013 · Diabetes
32. The role of structured education in the management of hypoglycaemia
    Iqbal, Ahmed, Heller, Simon R. · 2018 · Diabetologia
33. Continuous Glucose Monitoring: Evidence and Consensus Statement for Clinical Use
    Andreas Liebl, Helmut R. Henrichs, Lutz Heinemann, Guido Freckmann, Eberhard Biermann, Andreas Thomas · 2013 · Journal of Diabetes Science and Technology
34. Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers
    PERSIS V. COMMISSARIAT, Claire T. Boyle, Kellee M. Miller, Manasa Mantravadi, Daniel J. DeSalvo, William V. Tamborlane, Michelle Anne Van Name, Barbara J. Anderson, Linda Anne DiMeglio, Lori M. Laffel · 2017 · Diabetes Technology & Therapeutics
35. Realising the long-term promise of insulin therapy: the DCCT/EDIC study
    David M. Nathan · 2021 · Diabetologia
36. Substantial Increase in Incidence of Severe Hypoglycemia Between 1997–2000 and 2007–2010
    Andreas Holstein, Olaf M. Patzer, Kathrin Machalke, Judith D. Holstein, Michael Stümvoll, Peter Louis Kovacs · 2012 · Diabetes Care
37. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: The repose trial
    Heller, Simon, White, David, Lee, Ellen, Lawton, Julia, Pollard, Daniel, Waugh, Norman, Amiel, Stephanie, Barnard, Katharine, Beckwith, Anita, Brennan, Alan et al. · 2017 · Health Technology Assessment
38. Closed-Loop Insulin Delivery in Type 1 Diabetes
    Hood Thabit, Roman Hovorka · 2012 · Endocrinology and Metabolism Clinics of North America
39. 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
    Jun Sung Moon, Shinae Kang, Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Ji A Seo, Mee Kyoung Kim et al. · 2024 · Diabetes & Metabolism Journal
40. Insulin Pump Therapy
    Revital Nimri, Judith Nir, Moshe Phillip · 2019 · American Journal of Therapeutics
41. Methods for Insulin Delivery and Glucose Monitoring in Diabetes: Summary of a Comparative Effectiveness Review
    Sherita Hill Golden, Tamar Sapir · 2012 · Journal of Managed Care Pharmacy
42. Continuous Glucose Monitoring: Current Use and Future Directions
    Daniel J. DeSalvo, Bruce A. Buckingham · 2013 · Current Diabetes Reports
43. Morbidity and Mortality of Diabetic Ketoacidosis With and Without Insulin Pump Care
    Jaime Realsen, Hannah Goettle, H. Peter Chase · 2012 · Diabetes Technology & Therapeutics
44. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation
    Rob Riemsma, Isaac Corro Ramos, Richard Birnie, Nasuh Büyükkaramikli, Nigel Armstrong, Steve Ryder, Steven Duffy, Gill Worthy, Maiwenn Al, Johan Louis Severens et al. · 2016 · Health Technology Assessment
45. Psychology, technology, and diabetes management.
    Linda A Gonder-Frederick, Jaclyn A. Shepard, Jesse H. Grabman, Lee Michael Ritterband · 2016 · American Psychologist
46. Review of the Long-Term Implantable Senseonics Continuous Glucose Monitoring System and Other Continuous Glucose Monitoring Systems
    Jeffrey I. Joseph · 2020 · Journal of Diabetes Science and Technology
47. Quality of Life and Technology: Impact on Children and Families With Diabetes
    Masakazu Hirose, Elizabeth Ann Beverly, Katie Weinger · 2012 · Current Diabetes Reports
48. Canine-centered interface design
    Charlotte Robinson, Clara Mancini, Janet van der Linden, Claire Guest, Robert Harris · 2014 · CHI Conference on Human Factors in Computing Systems
49. Improved A1C Levels in Type 1 Diabetes with Smartphone App Use
    Ryan, Edmond A., Holland, Joanna, Stroulia, Eleni, Bazelli, Blerina, Babwik, Stephanie A., Li, Haipeng, Senior, Peter, Greiner, Russ · 2017 · Canadian Journal of Diabetes
50. Personal continuous glucose monitoring (CGM) in diabetes management: Review of the literature and implementation for practical use
    Joubert, M., Reznik, Y. · 2012 · Diabetes Research and Clinical Practice
51. The rise, fall, and resurgence of immunotherapy in type 1 diabetes
    Moufida Ben Nasr, Francesca D’Addio, Vera Usuelli, Sara Tezza, Reza Abdi, Paolo Fiorina · 2014 · Pharmacological Research
52. Monitoring Technologies- Continuous Glucose Monitoring, Mobile Technology, Biomarkers of Glycemic Control
    Nihaal Reddy, Neha Verma, Kathleen Marie Dungan · 2020 · MDText.com, Inc. eBooks
53. Monitoring Glycemic Control
    Berard, Lori D., Siemens, Rick, Woo, Vincent · 2018 · Canadian Journal of Diabetes
54. Glycemic outcomes of children 2–6 years of age with type 1 diabetes during the pediatric MiniMed ™ 670G system trial
    Gregory P. Forlenza, Laya Ekhlaspour, Linda Anne DiMeglio, Larry A. Fox, Henry Rodriguez, Dorothy I. Shulman, Kevin B. Kaiserman, David R. Liljenquist, John Shin, Scott W. Lee et al. · 2022 · Pediatric Diabetes
55. Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenges
    Anna J Wood, David Norman O'Neal, John Furler, Elif Ilhan Ekinci · 2018 · Internal Medicine Journal
56. Statement by the American Association of Clinical Endocrinologists Consensus Panel on Insulin Pump Management
    George Grunberger, Timothy Silleck Bailey, A. Jay Cohen, Thomas M. Flood, Yehuda Handelsman, Richard Hellman, Lois Jovanovič, Etie S. Moghissi, Eric A. Orzeck, AACE Insulin Pump Management Task Force · 2010 · Endocrine Practice
57. Impact of Long-Term Poor and Good Glycemic Control on Metabolomics Alterations in Type 1 Diabetic People
    Tumpa Dutta, Yogish C. Kudva, Xuan-Mai T. Persson, Louis A. Schenck, G. C. Ford, Ravinder Jit Singh, Rickey E. Carter, K. Sreekumaran Nair · 2016 · The Journal of Clinical Endocrinology & Metabolism
58. Time in range centered diabetes care
    Klemen Dovč, Tadej Battelino · 2021 · Clinical Pediatric Endocrinology
59. Implantable batteryless device for on-demand and pulsatile insulin administration
    Seung Ho Lee, Young Bin Lee, Byung Hwi Kim, Chul Lee, Young Min Cho, Se-Na Kim, Chun Gwon Park, Yong-Chan Cho, Young Bin Choy · 2017 · Nature Communications
60. Improved Real-World Glycemic Control With Continuous Glucose Monitoring System Predictive Alerts
    Abraham, Sinu Bessy, Arunachalam, Siddharth, Zhong, Alex, Agrawal, Pratik, Cohen, Ohad, McMahon, Chantal M. · 2021 · Journal of Diabetes Science and Technology
61. In vitro and in vivo testing of glucose-responsive insulin-delivery microdevices in diabetic rats
    Michael K. L. Chu, Jian Chen, Cláudia R. Gordijo, Simon Chiang, Alexander Ivovic, Khajag Koulajian, Adria Giacca, Xiao Yu Wu, Yu Sun · 2012 · Lab on a Chip
62. The Benefits, Limitations, and Cost-Effectiveness of Advanced Technologies in the Management of Patients With Diabetes Mellitus
    Robert Alan Vigersky · 2015 · Journal of Diabetes Science and Technology
63. Prediabetes in youth – mechanisms and biomarkers
    R. Weiss, N. Santoro, C. Giannini, A. Galderisi, G. Umano, S. Caprio · 2017 · The Lancet Child & Adolescent Health
64. How Patients With Type 1 Diabetes Translate Continuous Glucose Monitoring Data into Diabetes Management Decisions
    Jeremy Pettus, David A. Price, Steven V. Edelman · 2015 · Endocrine Practice
65. Overnight automated type 1 diabetes control under MD-logic closed-loop system: a randomized crossover trial
    Revital Nimri, Thomas Danne, Olga Kordonouri, Eran Atlas, Nataša Bratina, T Biester, Magdalena Avbelj Stefanija, Shahar Miller, Ido Muller, Moshe Phillip et al. · 2013 · Pediatric Diabetes
66. Continuous Glucose Monitoring and Global Reimbursement: An Update
    Claudia Graham · 2017 · Diabetes Technology & Therapeutics
67. Racial Disparities in Diabetes Technology Use and Outcomes in Type 1 Diabetes in a Safety-Net Hospital
    Fantasia, Kathryn L, Wirunsawanya, Kamonkiat, Lee, Christopher, Rizo, Ivania · 2021 · Journal of Diabetes Science and Technology
68. Factors Predictive of Severe Hypoglycemia in Type 1 Diabetes
    Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group · 2011 · Diabetes Care
69. Glycated hemoglobin A1c as a risk factor for severe hypoglycemia in pediatric type 1 diabetes: HbA1c and hypoglycemia risk
    Karges, Beate, Kapellen, Thomas, Wagner, Verena M, Steigleder-Schweiger, Claudia, Karges, Wolfram, Holl, Reinhard W, Rosenbauer, Joachim, for the DPV Initiative · 2017 · Pediatric Diabetes
70. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections
    Deborah Jane Holmes-Walker, Jenny Elizabeth Gunton, Wayne John Hawthorne, Marlene Payk, Patricia Anderson, Susan M Donath, Tom Loudovaris, Glenn M. Ward, Thomas W. H. Kay, Philip J. O’Connell · 2016 · Transplantation
71. Introduction to ISPAD Clinical Practice Consensus Guidelines 2014 Compendium
    Carlo L. Acerini, Maria E. Craig, Carine E. de Beaufort, David M. Maahs, Ragnar Hanås · 2014 · Pediatric Diabetes
72. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons
    Hood Thabit, Roman Hovorka · 2015 · Expert Opinion on Drug Delivery
73. Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas
    Gregory P. Forlenza, Bruce A. Buckingham, David M. Maahs · 2015 · The Journal of Pediatrics
74. Managing hypoglycaemia
    Ahmed Iqbal, Simon R. Heller · 2016 · Best Practice & Research Clinical Endocrinology & Metabolism
75. The Bile Acid TUDCA Improves Beta-Cell Mass and Reduces Insulin Degradation in Mice With Early-Stage of Type-1 Diabetes
    Gabriela Alves Bronczek, Jean Franciesco Vettorazzi, Gabriela Moreira Soares, Mirian Ayumi Kurauti, Cristiane dos Santos, Maressa Fernandes Bonfim, Everardo M. Carneiro, Sandra Lucinei Balbo, Antonio Carlos Boschero, José Maria Costa Júnior · 2019 · Frontiers in Physiology
76. Pancreatic islet transplantation: current advances and challenges
    Qi Wang, Yu-xi Huang, Long Liu, Xiao-hong Zhao, Yi Sun, Xin-Li Mao, Shao-wei Li · 2024 · Frontiers in Immunology
77. Automated Overnight Closed-Loop Glucose Control in Young Children with Type 1 Diabetes
    Daniela Elleri, Janet M. Allen, Marianna Nodale, Malgorzata E. Wilinska, Jasdip S. Mangat, Anne Mette F. Larsen, Carlo L. Acerini, David B. Dunger, Roman Hovorka · 2011 · Diabetes Technology & Therapeutics
78. Current Application of Continuous Glucose Monitoring in the Treatment of Diabetes
    Jeroen Hermanides, Moshe Phillip, J. Hans DeVries · 2011 · Diabetes Care
79. Overweight, obesity and features of metabolic syndrome in children with diabetes treated with insulin pump therapy
    Włodzimierz Łuczyński, Agnieszka Szypowska, Barbara Głowińska‐Olszewska, Artur Tadeusz Bossowski · 2010 · European Journal of Pediatrics
80. Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus
    Tadej Battelino, Severine Liabat, Henk J. Veeze, Javier Castañeda, Arcelia Arrieta, Ohad Cohen · 2015 · Diabetic Medicine
81. Nonadjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions
    Jessica R. Castle, Peter G. Jacobs · 2016 · Journal of Diabetes Science and Technology
82. Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes
    Isabelle Isa Kristin Steineck, Ajenthen Gayathri Ranjan, Kirsten Nørgaard, Signe Schmidt · 2016 · Journal of Diabetes Science and Technology
83. Communication protocols integrating wearables, ingestibles, and implantables for closed-loop therapies
    Ramy W. Ghanim, Anika Kaushik, Jihoon Park, Alex Abramson · 2023 · Device
84. An Online Failure Detection Method of the Glucose Sensor-Insulin Pump System: Improved Overnight Safety of Type-1 Diabetic Subjects
    Facchinetti, Andrea, Favero, Simone, Sparacino, Giovanni, Cobelli, Claudio · 2013 · IEEE Transactions on Biomedical Engineering
85. International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring
    Martin Tauschmann, Roque Cardona‐Hernandez, Daniel J. DeSalvo, Korey K. Hood, Д. Н. Лаптев, Anna Lindholm Olinder, Benjamin John Wheeler, Carmel E. Smart · 2025 · Hormone Research in Paediatrics
86. Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps
    Pauline Schaepelynck, Patrice Darmon, Laurent Molines, Marie-Françoise Jannot-Lamotte, Clémence Tréglia, D. Raccah · 2011 · Diabetes & Metabolism
87. Diagnosis, Therapy and Follow-Up of Diabetes Mellitus in Children and Adolescents
    Andreas Neu, Jutta Bürger-Büsing, Thomas Danne, Axel Dost, Martin Holder, Reinhard Walter Holl, Paul‐Martin Holterhus, Thomas Michael Kapellen, Beate Karges, Olga Kordonouri et al. · 2019 · Experimental and Clinical Endocrinology & Diabetes
88. New-generation diabetes management: glucose sensor-augmented insulin pump therapy
    Eda Cengiz, Jennifer L. Sherr, STUART ALAN WEINZIMER, William V. Tamborlane · 2011 · Expert Review of Medical Devices
89. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes
    JOHAN H. JENDLE, Johannes Pöhlmann, Simona de Portu, Jayne Smith‐Palmer, Stéphane Roze · 2019 · Diabetes Technology & Therapeutics
90. Hypoglycaemia in type 1 diabetes: technological treatments, their limitations and the place of psychology
    Choudhary, Pratik, Amiel, Stephanie A. · 2018 · Diabetologia
91. Clinical Management of the Physically Active Patient with Type 1 Diabetes
    Lisa Chu, Jill K. Hamilton, Michael Charles Riddell · 2011 · The Physician and Sportsmedicine
92. The Immunoproteasome: An Emerging Target in Cancer and Autoimmune and Neurological Disorders
    Breanna L. Zerfas, Marianne E. Maresh, Darci Jones Trader · 2019 · Journal of Medicinal Chemistry
93. Severe Hypoglycemia: Is It Still a Threat for Children and Adolescents With Type 1 Diabetes?
    Tatsuhiko Urakami · 2020 · Frontiers in Endocrinology
94. Distinctions Between the Islets of Mice and Men: Implications for New Therapies for Type 1 and 2 Diabetes
    Claresa S. Levetan, Susan M. Pierce · 2012 · Endocrine Practice
95. Evolution of Devices in Diabetes Management
    Penfornis, Alfred, Personeni, Estelle, Borot, Sophie · 2011 · Diabetes Technology & Therapeutics
96. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: aWeSoMe study group real-life observational experience
    Landau, Zohar, Abiri, Shirli, Gruber, Noah, Levy-Shraga, Yael, Brener, Avivit, Lebenthal, Yael, Barash, Galia, Pinhas-Hamiel, Orit, Rachmiel, Mariana · 2018 · Acta Diabetologica
97. A Pharmacokinetic Model of a Tissue Implantable Insulin Sensor
    Gili Bisker, Nicole M. Iverson, Jiyoung Ahn, Michael S. Strano · 2014 · Advanced Healthcare Materials
98. Experiences of Continuous Subcutaneous Insulin Infusion in Pregnant Women with Type 1 Diabetes During Delivery from Four Italian Centers: A Retrospective Observational Study
    Raffaella Fresa, Natalia Visalli, Vincenzo Di Blasi, Vincenzo Cavallaro, Egle Ansaldi, Oria Trifoglio, Santina Abbruzzese, Marzia Bongiovanni, Mariano Agrusta, Angela Napoli · 2013 · Diabetes Technology & Therapeutics
99. Influences on Technology Use and Efficacy in Type 1 Diabetes
    Victoria Louise Franklin · 2016 · Journal of Diabetes Science and Technology
100. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.
     G. Grunberger, Y. Handelsman, Z. Bloomgarden, V. Fonseca, A. Garber, R. Haas, V. Roberts, G. Umpierrez · 2018 · Endocrine Practice